Drug Shortage Report for ATROPINE SULFATE INJECTION USP

Last updated on 2024-12-18 History
Report ID 241114
Drug Identification Number 00328154
Brand name ATROPINE SULFATE INJECTION USP
Common or Proper name ATROPINE SULFATE INJECTION USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) ATROPINE SULFATE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10 x 10mL LifeShield
ATC code A03BA
ATC description BELLADONNAAND DERIVATIVES, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-10-24
Estimated end date 2025-06-30
Actual end date
Shortage status Actual shortage
Updated date 2024-12-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2024-12-18 French Compare
v3 2024-12-18 English Compare
v2 2024-10-25 French Compare
v1 2024-10-25 English Compare

Showing 1 to 4 of 4